Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $35.70 | Total: $178.50 |
| 1 | 10 | $30.24 | Total: $302.40 |
| 1 | 25 | $25.62 | Total: $640.50 |
| 1 | 50 | $21.84 | Total: $1,092.00 |
| 1 | 100 | $18.90 | Total: $1,890.00 |
Overview
Droloxifene (3-Hydroxytamoxifen), a tamoxifen derivative, is an oral active and selective estrogen receptor modulator.Droloxifene induced p53 expression and apoptosis in McF-7 cells.Fluroxifene has anti-estrogen and anti-implantation effects.Fluroxifene prevented bone loss in ovariectomized rats.
Chemical Properties
| Molecular Formula | C26H29NO2 |
| Molecular Weight | 387.51 |
| CAS Numbers | 82413-20-5 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CCC(=C(c1ccc(OCCN(C)C)cc1)c1cccc(O)c1)c1ccccc1 |
Storage and Handling
0C Short Term, -20C Long Term
References
Herrington DM, et al. Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthypostmenopausal women. Arterioscler Thromb Vasc Biol. 2000 Jun;20[6] 1606-12.